Loading...
01/11 04:04
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed picture: positive aspects include a 7.3% sales increase and improved margins, but EPS fell short of expectations. Raised EBITDA guidance and a strong backlog offer optimism, yet competitive pressures and economic uncertainties pose risks. The Q&A indicates cautious optimism but lacks clarity on key issues like M&A and budget impacts. With no share repurchase program, the sentiment remains mixed, leading to a neutral outlook for stock price movement.
Earnings Per Share (EPS) Reported EPS is $0.1442, a decrease from expectations of $0.16.
Sales Sales for the quarter totaled $47 million, a 7.3% increase over last year, driven by growth across key end markets including chemical, petrochemical, space, defense, and the commercial aftermarket.
Gross Margin Gross margin expanded by 260 basis points to 24.8%, driven by higher sales volume, favorable project mix, enhanced pricing, and better execution.
Adjusted EBITDA Adjusted EBITDA totaled $4 million, a 36% increase over the prior year, with an adjusted EBITDA margin of 8.6%, representing a 180 basis point improvement.
Net Income GAAP net income reached $1.6 million, a $1.4 million increase from the same period of fiscal 2024, translating to $0.14 per diluted share.
Capital Expenditures Capital expenditures totaled $7.3 million, with expectations for fiscal 2025 now in the range of $15 million to $19 million, up from previous guidance of $13 million to $18 million.
Backlog Backlog totaled $385 million as of December 31, with 80% from the Defense business, providing excellent visibility into future sales.
Orders Orders for the quarter declined to $24.8 million, but for the nine-month period, orders were $144.2 million, equating to a book-to-bill ratio of one times revenue.
Effective Tax Rate Effective tax rate for the quarter was 29%, with a year-to-date rate of 20%, reflecting a decrease due to a discrete tax benefit recognized in the first quarter.
NextGen nozzle: The response to our NextGen nozzle launched in October has been very positive and we have just received our second order.
Defense backlog: Our Defense business represented 80% of our backlog at December 31.
Space backlog: Our space backlog increased 59% over last year or nearly $7 million.
New Batavia manufacturing facility: Construction of the Graham facility is progressing well and remains on schedule for completion in June of this year.
Cryogenic propellant test facility: The facility is continuing to progress towards construction and will provide a scalable cost effective alternative to existing centers.
Leadership transition: A two phase leadership transition has been implemented, with Matt Malone appointed as President and COO, and Dan Thoren transitioning to Executive Chairman.
R&D investments: Expanded R&D investments and capital programs are powering key growth initiatives with a target return on invested capital exceeding 20%.
Earnings Expectations: Graham Corporation missed earnings expectations with a reported EPS of $0.1442, below the expected $0.16.
Regulatory Issues: The company mentioned potential risks related to regulatory compliance, particularly in defense contracts and environmental regulations.
Supply Chain Challenges: There are ongoing supply chain challenges that could impact project timelines and costs, particularly in the context of new manufacturing facilities and equipment.
Competitive Pressures: The company faces competitive pressures in the defense and aerospace sectors, which may affect pricing and market share.
Economic Factors: Economic uncertainties, including inflation and interest rate fluctuations, could impact customer spending and project funding.
Leadership Transition: The leadership transition may pose risks related to strategic continuity and execution during the changeover period.
Project Timing: The timing of projects, particularly in the refining sector, has been noted as a risk factor affecting revenue.
Investment Risks: The company is increasing capital expenditures, which carries risks related to return on investment and project execution.
Leadership Transition: A two-phase leadership transition is being implemented, with Matt Malone appointed as President and COO, and Dan Thoren transitioning to Executive Chairman focusing on Strategic Advisory and Business Development.
Manufacturing Facility Expansion: Construction of a new 29,000 square foot manufacturing facility in Batavia is on schedule for completion in June 2025, enhancing capabilities for naval defense work.
Cryogenic Propellant Test Facility: A state-of-the-art cryogenic propellant test facility is under construction, expected to begin initial testing by mid-2025, serving various critical programs.
R&D Investments: Continued investments in R&D and operational excellence are aimed at driving long-term growth.
Strategic Acquisitions: The company remains opportunistic for potential strategic acquisitions to support growth.
Revenue Guidance: Fiscal 2025 revenue is anticipated to be between $200 million and $210 million, reflecting an 11% growth over fiscal 2024.
Adjusted EBITDA Guidance: Adjusted EBITDA is expected to be between $18 million and $21 million, implying a 47% growth over the prior year.
Gross Margin Guidance: Gross margin guidance has been increased to a range of 24% to 25%, up from the previously expected 23% to 24%.
SG&A Expense Guidance: SG&A expenses are now expected to be in the range of 18% to 19% of sales, up from 17% to 18%.
Capital Expenditures Guidance: Capital expenditures for fiscal 2025 are expected to be in the range of $15 million to $19 million.
Long-term Financial Goals: The company aims for 8% to 10% organic revenue growth per year and low to mid-teen adjusted EBITDA margins by fiscal 2027.
Share Repurchase Program: None
The earnings call reveals strong financial performance with a 15% increase in aftermarket sales and a 12% rise in gross profit. Despite maintaining guidance, the company has strategic investments and new facilities that are expected to drive growth. The Q&A section indicates healthy backlog and customer interest, minimal impact from government shutdowns, and promising developments in various markets. While some details were vague, the overall sentiment is positive due to strong revenue growth, strategic investments, and diversified defense orders.
The earnings call summary indicates strong financial performance, strategic growth initiatives, and optimistic guidance, despite some uncertainties in margin sustainability. The Q&A highlights robust aftermarket sales, a growing defense backlog, and promising opportunities in nuclear and space sectors. While management is cautious about future margins, the overall sentiment is positive with a record backlog and strategic investments. The absence of significant hiring challenges and a clear strategy for international growth further support a positive outlook. These factors suggest a likely stock price increase of 2% to 8% over the next two weeks.
The company reported strong financial performance with significant year-over-year growth in revenue, EBITDA, and net income. Despite competitive pressures and some regulatory and supply chain risks, the management provided optimistic guidance for fiscal 2026. The Q&A session highlighted robust M&A opportunities and successful integration efforts. However, the absence of a share repurchase program and some lack of clarity on facility utilization rates slightly tempered the outlook. Overall, the strong financial results and optimistic guidance suggest a positive stock price movement.
The earnings call presents a mixed picture: positive aspects include a 7.3% sales increase and improved margins, but EPS fell short of expectations. Raised EBITDA guidance and a strong backlog offer optimism, yet competitive pressures and economic uncertainties pose risks. The Q&A indicates cautious optimism but lacks clarity on key issues like M&A and budget impacts. With no share repurchase program, the sentiment remains mixed, leading to a neutral outlook for stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
